Literature DB >> 9050

Determination of lorazepam in plasma by electron capture GLC.

G de Groot, R A Maes, H H Lemmens.   

Abstract

A method is described for the determination of lorazepam plasma levels involving extraction from the sample and analysis of the intact lorazepam by electron capture gas-liquid chromatography. Using mass spectrometry it is demonstrated, that lorazepam shows a thermal rearrangement under gas chromatographic conditions. The limit of detection is 0.01 mg/l and the assay shows a linearity from 0.01-0.80 mg lorazepam per liter of plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9050     DOI: 10.1007/BF00293571

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  11 in total

1.  [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group].

Authors:  P Appel; I Berger; G Harrer
Journal:  Arzneimittelforschung       Date:  1971-07

2.  Toxicity studies of lorazepam, a new benzodiazepine, in animals.

Authors:  G Owen; G K Hatfield; J J Pollock; A J Steinberg; W E Tucker; H P Agersborg
Journal:  Arzneimittelforschung       Date:  1971-07

3.  Thermolysis of 1,4-benzodiazepines during gas chromatography and mass spectroscopy.

Authors:  W Sadée; E Van der Kleijn
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

4.  Initial psychopharmacological study of lorazepam (Wy 4036).

Authors:  J Collard
Journal:  Arzneimittelforschung       Date:  1971-07

5.  [Therapy of the primary symptom anxiety in neuroses, abnormal experience reactions, neuro-vegative psychosomatic disorders and depressions].

Authors:  H Guthy; J Hildgen; G Brinkmann
Journal:  Arzneimittelforschung       Date:  1971-07

6.  [Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine].

Authors:  H Leube; H Höffkes
Journal:  Arzneimittelforschung       Date:  1971-07

7.  [Testing of lorazepam (Wy 4036) in the neurological practice].

Authors:  W Meusert
Journal:  Arzneimittelforschung       Date:  1971-07

8.  Disposition of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in humans. Determination of the drug by electron capture gas chromatography.

Authors:  J A Knowles; W H Comer; H W Ruelius
Journal:  Arzneimittelforschung       Date:  1971-07

9.  [Clinical studies on Wy 4036 (lorazepam), a new tranquilizing agent].

Authors:  O Schrappe
Journal:  Arzneimittelforschung       Date:  1971-07

10.  Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy 4036).

Authors:  M I Gluckman
Journal:  Arzneimittelforschung       Date:  1971-07
View more
  1 in total

Review 1.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.